App-Quantinova.ai

Incidence of Cerebral Ischemia After Discontinuation Of Clopidogrel (Plavix) In Patients With Cerebral Aneurysms Treated Using Stent-Assisted Technique

Jacob Thomas - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Clopidogrel bisulfate

Ischemic Stroke with Early AM Onset is More Severe but Less Frequent

Karen C. Albright - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Safety And Efficacy Of Anticoagulation In Patients With Cerebral Venous Sinus Thrombosis Presenting With Subarachnoid Hemorrhage.

Maricela Reyes - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Heparin

Embolus Adhesion to Activated Endothelium After Embolization: A Parameter To Predict Outcomes Of Mechanical Thrombectomy In Acute Ischemic Stroke

Anna Luisa Kuhn - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Long-term Recurrence of Venous Thrombotic Events After Cerebral Vein Thrombosis

Antonio Arauz - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Substance Abuse

Venous thrombosis

N/A

Extraluminal Protruding Plaques in Intracranial Arteries. An angiographic and pathological analysis of Circle of Willis specimens from the Nun Study

Shahram Majidi - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Vista

Epilepsy as a Long-Term Complication After Cerebral Venous Thrombosis

Erwin Chiquete Sr - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Tissue Plasminogen Activator Exerts Neurotoxic Effects Despite Successful Thrombus Dissolution in Ischemic Stroke

Dong Wang - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Clinical characteristics, Presentation and Outcomes of Percutaneous Coronary Intervention among HIV-positive Patients Compared to Controls: A Comprehensive Meta-Analysis of Existing Studies

Mahboob Alam - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Long-term Outcomes After Sirolimus-Eluting Stent Implantation for Calcified Coronary Lesions: Insights From the j-Cypher Registry

Takeshi Kimura - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

sirolimus

The Comparison of Warfarin and Dabigatran in the Incidence of Asymptomatic Cerebral Micro Thromboembolism after AF Ablation

Naoya Oketani - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Pradax

Pre-procedure C-reactive Protein and Erythrocyte Sedimentation Rate but not Lipoprotein-associated Phospholipase A2 Predict Clinical Outcomes after Drug-eluting Stents Implantation in Patients with Stable Coronary Disease on Chronic Statin Therapy

Vitaly Buza - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Late Malapposition and Endothelial Coverage of Drug-Eluting-Stents - A Prospective Optical Coherence Tomography Study

Clemens Gangl - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

ZoMaxx

Impact of Lesion Morphology on Angiographic and Clinical Outcomes in Patients With Chronic Total Occlusion After Successful Recanalization With Drug-eluting stents. A Multislice Computed Tomography Study

Etsuo Tsuchikane - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Potent Antithrombotic Effect of a Small-molecule, Reversible and Direct Inhibitor of Factor XIa With Minimum Bleeding Time Effect In Rabbit Models of Arterial Thrombosis and Hemostasis

Mimi Quan - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

BMS-654457

Left Atrial Appendage Contractility Assessed by Speckle Tracking Transesophageal Echocardiography as a Determinant of Thrombus Formation in Patients Receiving Warfarin for Chronic Atrial Fibrillation: beyond CHADS2 and CHA2DS2-VASc Score

Masanori Kawasaki - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Warfarin

Safety and Efficacy of Once Daily 220 mg Dabigatran Etexilate in a Real-World NonInterventional Study of More Than 5000 Patients After Total Knee or Hip Replacement

Charles Marc Samama - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Pradax

Six and Twelve-month Clinical and Imaging Results of the Multicenter First-in-man BIOSOLVE-I Study with the Paclitaxel-Eluting Bioabsorbable Magnesium Scaffold (DREAMS)

Stadtische Kliniken-Neuss - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Paclitaxel

Myocardial Infarction is not a Risk Factor for Hospital-Acquired Venous Thrombosis: The Medical Inpatients Thrombosis (MITH) Study

Peter W Callas - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Molecular MRI of Activated Platelets Using Anti-LIBS-magnetoliposomes as a New Strategy for Timely Detection of Unstable Plaques

Gerd Putz - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Filters

7277 Abstracts